Drug Res (Stuttg) 2015; 65(05): 266-271
DOI: 10.1055/s-0034-1377004
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Synthesis and Biological Evaluation of Some New Amide Moiety Bearing Quinoxaline Derivatives as Antimicrobial Agents

U. Abu Mohsen
1   Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Al-Azhar University, Gaza, Palestine
,
L. Yurttaş
2   Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskisehir, Turkey
,
U. Acar
2   Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskisehir, Turkey
,
Y. Özkay
2   Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskisehir, Turkey
,
Z. A. Kaplacikli
2   Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskisehir, Turkey
,
H. Karaca Gencer
3   Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Anadolu University, Eskisehir, Turkey
,
Z Cantürk
3   Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Anadolu University, Eskisehir, Turkey
› Author Affiliations
Further Information

Publication History

received 27 March 2014

accepted 09 May 2014

Publication Date:
11 June 2014 (online)

Abstract

In this study, we aimed to synthesize some new quinoxaline derivatives bearing amide moiety and to evaluate their antimicrobial activity. A set of 16 novel compounds of N-[2,3-bis(4-methoxy/methylphenyl)quinoxalin-6-yl]-substituted benzamide derivatives were synthesized by reacting 2,3-bis(4-methoxyphenyl)-6-aminoquinoxaline or 2,3-bis(4-methylphenyl)-6-aminoquinoxaline with benzoyl chloride derivatives in tetrahydrofuran and investigated for their antimicrobial activity. The structures of the obtained final compounds were confirmed by spectral data (IR, 1H-NMR, 13C-NMR and MS). The antimicrobial activity of the compounds were determined by using the microbroth dilution method. Antimicrobial activity results revealed that synthesized compounds exhibited remarkable activity against Candida krusei (ATCC 6258) and Candida parapsilosis (ATCC 22019).

 
  • References

  • 1 Fostel JM, Lartey PA. Emerging novel antifungal agents. Drug Discov Today 2000; 5: 25-32
  • 2 Özkay Y, Işıkdağ I, Tunalı Y et al. Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moiety. Eur J Med Chem 2010; 45: 3293-3298
  • 3 Crabb C. Global alliance at full steam for new TB drugs. Bull Word Health Organ 2002; 80: 517
  • 4 Badran MM, Abonzid KA, Hussein MH. Synthesis of certain substituted quinoxalines as antimicrobials agents. Part II. Arch Pharm Res 2003; 26: 107-113
  • 5 Griffith RK, Chittur SV, Chen YC. Inhibition of glucosamine-6-phosphate synthase from candida albicans by quinoxaline-2, 3-diones. Med Chem Res 1992; 2: 467-473
  • 6 El-Gendy AA, El-Meligie S, El-Ansry A et al. Synthesis of some quinoxaline derivatives containing indoline-2,3-dione or, thiazolidine residue as potential antimicrobials agents. Arch Pharm Res 1995; 18: 44-47
  • 7 Reddy-Sastry CV, Shrinivas-Rao K, Krishanan VSH et al. Synthesis and biological activity of some new tetrazolobenzoxazines as bis-tetrazoloquinoxalines. Indian J Chem 1990; 29: 396-403
  • 8 El-Hawash SA, Habib NS, Franki NH. Synthesis and antimicrobial testing of 1,2,4- triazolo[4,3-a]quinoxalines, 1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines. Pharmazie 1999; 54: 808-815
  • 9 Sen Gupta AK, Misra HK. Synthesis and evaluation of substituted quinazolone derivatives for antibacterial, antifungal, and antiacetyl-cholinesterase activities. J Pharm Sci 1980; 69: 1313-1317
  • 10 Misra HK. Synthesis of some new substituted 1,3,4-oxadiazolesas potential insecticidal, antibacterial and anti-acetylcholine esterase agents. Arch Pharm 1983; 316: 487-493
  • 11 Bhat AR, Bhat GV, Shenoy GG. Synthesis and in vitro antimicrobial activity of new 1,2,4-triazoles. J Pharm Pharmacol 2001; 53: 267-272
  • 12 Collin X, Sauleau A, Coulon J. 1,2,4-Triazolo mercapto and aminonitriles as potent antifungal agents. Bioorg Med Chem Lett 2003; 13: 2601-2605
  • 13 Lemke TL, Williams DA. Foye’s Principles of Medicinal Chemistry. Lippincott Williams & Wilkins; Baltimore: 2008
  • 14 Soliman DH. Synthesis, characterization, anti-bacterial and anti-fungal activities of new quinoxaline 1,4-di-N-oxide derivatives. Inter J Org Chem 2013; 3: 65-72
  • 15 Heravi MM, Bakhtiari K, Bamoharram FF et al. Wells-Dawson-type heteropolyacid-catalyzed synthesis of quinoxaline derivatives at room temperature. Monat Chem 2007; 138: 465-467
  • 16 Guo WX, Jin HL, Chen JX et al. An efficient catalyst-free protocol for the synthesis of quinoxaline derivatives under ultrasound irradiation. J Braz Chem Soc 2006; 20: 174-179
  • 17 Kumar K, Ramakrishna G, Ajay A et al. Chemoselective synthesis of polyfunctional aminophenyl 2-oxobut-3-enyl- and quinolinylmethyl-C-glycopyranosides from nitrophenyl 2-oxobut-3-enyl C-glycopyranosides under ultrasonic vibration. Arkivoc 2013; (ii) 146-165
  • 18 Gilman H, Broadbent HS. Some basically substituted quinoxalines. J Am Chem Soc 1948; 70: 2619-2621
  • 19 CLSI . Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved Standard, CLSI Document M7-A7. 7th Ed. ISBN 1-56238 2006: 587-589
  • 20 Yurttaş L, Özkay Y, Karaca H et al. Synthesis and antimicrobial evaluation of some 2,5-disubstituted benzimidazole derivatives. Lett Drug Des Discov 2013; 10: 486-491